Jade Biosciences, Inc. Stock Price

NasdaqCM:JBIO Community·US$718.1m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create a narrative

JBIO Share Price Performance

US$15.61

5.47 (53.94%)

US$15.61

5.47 (53.94%)

US$15.61

Sun, 1 Feb 26

Share Pricen/a

JBIO Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks

0 Rewards

View Full Analysis

Jade Biosciences, Inc. Key Details

Last Reported Earnings

Dec 31, 2024

Next Reporting Earnings

n/a

: -2.04
: 0%
: 0%
: -229.9%

View Full Analysis

About JBIO

Founded: n/a
Employees: 30
CEO: Tom Frohlich
WebsiteView website: jadebiosciences.com

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. It also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.